Lassen Therapeutics
Healthcare & Life Sciences
Recent Finacing
Series B
Recent Raise
$85M
Lassen Therapeutics is a clinical-stage biotech company developing novel treatments for fibro-inflammatory diseases and cancer, focusing on therapies targeting the IL-11 and IL-18 pathways.
Focus Areas
Clinical-stage biotech
IL-11 receptor
Fibro-inflammatory diseases
Monoclonal antibody
IL-18 binding protein
Cancer treatment
Investors
